1 Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018 68, 394-424, doi:10.3322/caac.21492.
2 Cancer Genome Atlas Research, N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014 507, 315-322, doi:10.1038/nature12965.
3 Boehm, B. E. & Svatek, R. S. Novel Therapeutic Approaches for Recurrent Nonmuscle Invasive Bladder Cancer. Urologic Clinics of North America 2015 42, 159-168, doi:10.1016/j.ucl.2015.02.001.
4 Genebank. https://cipotato.org/genebankcip/. Accessed 18 Jan 2020.
5 Kuja-Panula, J., Kiiltomäki, M., Yamashiro, T., Rouhiainen, A. & Rauvala, H. AMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats. The Journal of Cell Biology 2003 160, 963-973, doi:10.1083/jcb.200209074.
6 Rabenau, K. E., O'Toole, J. M., Bassi, R., Kotanides, H., Witte, L., Ludwig, D. L. & Pereira, D. S. DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity. Oncogene 2004 23, 5056-5067, doi:10.1038/sj.onc.1207681.
7 Fontanals-Cirera, B., Hasson, D., Vardabasso, C., Di Micco, R., Agrawal, P., Chowdhury, A., Gantz, M., de Pablos-Aragoneses, A., Morgenstern, A., Wu, P., Filipescu, D., Valle-Garcia, D., Darvishian, F., Roe, J. S., Davies, M. A., Vakoc, C. R., Hernando, E. & Bernstein, E. Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene. Mol Cell 2017 68, 731-744 e739, doi:10.1016/j.molcel.2017.11.004.
8 Wang, B., Xu, D., Yu, X., Ding, T., Rao, H., Zhan, Y., Zheng, L. & Li, L. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Ann Surg Oncol 2011 18, 2585-2593, doi:10.1245/s10434-011-1609-3.
9 Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nature Protocols 2008 3, 1101-1108, doi:10.1038/nprot.2008.73.
10 Sebaugh, J. L. Guidelines for accurate EC50/IC50 estimation. Pharm Stat 2011 10, 128-134, doi:10.1002/pst.426.
11 Cumashi, A., Tinari, N., Rossi, C., Lattanzio, R., Natoli, C., Piantelli, M. & Iacobelli, S. Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. Cancer Lett 2008 270, 229-233, doi:10.1016/j.canlet.2008.05.007.
12 Yang, Z., Liang, X., Fu, Y., Liu, Y., Zheng, L., Liu, F., Li, T., Yin, X., Qiao, X. & Xu, X. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma. EBioMedicine 2019 47, 44-57, doi:10.1016/j.ebiom.2019.08.013.
13 The Cancer Genome Atlas Program. https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga. 19 Nov 2019.
14 Malumbres, M. & Barbacid, M. Cell cycle, CDKs and cancer: a changing paradigm. Nature Reviews Cancer 2009 9, 153-166, doi:10.1038/nrc2602.
15 Sitko, J. C., Yeh, B., Kim, M., Zhou, H., Takaesu, G., Yoshimura, A., McBride, W. H., Jewett, A., Jamieson, C. A. & Cacalano, N. A. SOCS3 regulates p21 expression and cell cycle arrest in response to DNA damage. Cell Signal 2008 20, 2221-2230, doi:10.1016/j.cellsig.2008.08.011.
16 Lagunas-Cruz, M. D. C., Valle-Mendiola, A., Trejo-Huerta, J., Rocha-Zavaleta, L., Mora-Garcia, M. L., Gutierrez-Hoya, A., Weiss-Steider, B. & Soto-Cruz, I. IL-2 Induces Transient Arrest in the G1 Phase to Protect Cervical Cancer Cells from Entering Apoptosis. J Oncol 2019 2019, 7475295, doi:10.1155/2019/7475295.
17 Dasari, S. & Tchounwou, P. B. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 2014 740, 364-378, doi:10.1016/j.ejphar.2014.07.025.
18 Holohan, C., Van Schaeybroeck, S., Longley, D. B. & Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nature Reviews Cancer 2013 13, 714, doi:10.1038/nrc3599.
19 Anreddy, N., Gupta, P., Kathawala, R. J., Patel, A., Wurpel, J. N. & Chen, Z. S. Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance. Molecules 2014 19, 13848-13877, doi:10.3390/molecules190913848.
20 Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E. & Gottesman, M. M. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer 2018 18, 452-464, doi:10.1038/s41568-018-0005-8.
21 Faura Tellez, G., Willemse, B. W., Brouwer, U., Nijboer-Brinksma, S., Vandepoele, K., Noordhoek, J. A., Heijink, I., de Vries, M., Smithers, N. P., Postma, D. S., Timens, W., Wiffen, L., van Roy, F., Holloway, J. W., Lackie, P. M., Nawijn, M. C. & Koppelman, G. H. Protocadherin-1 Localization and Cell-Adhesion Function in Airway Epithelial Cells in Asthma. PLoS One 2016 11, e0163967, doi:10.1371/journal.pone.0163967.
22 Tatin, F., Taddei, A., Weston, A., Fuchs, E., Devenport, D., Tissir, F. & Makinen, T. Planar cell polarity protein Celsr1 regulates endothelial adherens junctions and directed cell rearrangements during valve morphogenesis. Dev Cell 2013 26, 31-44, doi:10.1016/j.devcel.2013.05.015.
23 Ortega, A., Gil-Cayuela, C., Tarazon, E., Garcia-Manzanares, M., Montero, J. A., Cinca, J., Portoles, M., Rivera, M. & Rosello-Lleti, E. New Cell Adhesion Molecules in Human Ischemic Cardiomyopathy. PCDHGA3 Implications in Decreased Stroke Volume and Ventricular Dysfunction. PLoS One 2016 11, e0160168, doi:10.1371/journal.pone.0160168.
24 Huang, S. & Ingber, D. E. The structural and mechanical complexity of cell-growth control. Nature Cell Biology 1999 1, E131-E138, doi:10.1038/13043.
25 Kanda, Y., Osaki, M., Onuma, K., Sonoda, A., Kobayashi, M., Hamada, J., Nicolson, G. L., Ochiya, T. & Okada, F. Amigo2-upregulation in Tumour Cells Facilitates Their Attachment to Liver Endothelial Cells Resulting in Liver Metastases. Sci Rep 2017 7, 43567, doi:10.1038/srep43567.
26 Chen, J., Gu, L., Ni, J., Hu, P., Hu, K. & Shi, Y. L. MiR-183 Regulates ITGB1P Expression and Promotes Invasion of Endometrial Stromal Cells. Biomed Res Int 2015 2015, 340218, doi:10.1155/2015/340218.
27 Carabia, J., Carpio, C., Abrisqueta, P., Jimenez, I., Purroy, N., Calpe, E., Palacio, C., Bosch, F. & Crespo, M. Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia. Sci Rep 2017 7, 12262, doi:10.1038/s41598-017-12135-7.
28 Zhu, H. E., Yin, J. Y., Chen, D. X., He, S. & Chen, H. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway. Cell Death Dis 2019 10, 854, doi:10.1038/s41419-019-2082-3.
29 Matsumoto, R., Tsuda, M., Yoshida, K., Tanino, M., Kimura, T., Nishihara, H., Abe, T., Shinohara, N., Nonomura, K. & Tanaka, S. Aldo-keto reductase 1C1 induced by interleukin-1beta mediates the invasive potential and drug resistance of metastatic bladder cancer cells. Sci Rep 2016 6, 34625, doi:10.1038/srep34625.
30 Doig, C. L., Battaglia, S., Khanim, F. L., Bunce, C. M. & Campbell, M. J. Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells. J Steroid Biochem Mol Biol 2016 155, 47-55, doi:10.1016/j.jsbmb.2015.09.037.
31 Liu, C., Yang, J. C., Armstrong, C. M., Lou, W., Liu, L., Qiu, X., Zou, B., Lombard, A. P., D'Abronzo, L. S., Evans, C. P. & Gao, A. C. AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer. Mol Cancer Ther 2019 18, 1875-1886, doi:10.1158/1535-7163.MCT-18-1322.
32 Julian, C. D. e. a. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res 2003 63, 505-512.